The newly introduced Haryana pharma policy 2026 marks a revolutionary step for India’s healthcare sector. Consequently, the Association of Indian Medical Device Industry (AiMeD) has strongly welcomed this progressive framework. For professionals looking to stay ahead in this evolving landscape, pursuing specialized pharmacy training is increasingly vital.
Key Incentives of the Haryana Pharma Policy 2026
Firstly, this policy aims to attract investments exceeding ten thousand crore rupees. Additionally, it targets the creation of twenty thousand local jobs. Therefore, the state government offers massive capital subsidies up to thirty percent. Specifically, a cap of two hundred crore rupees applies to capital expenditure. Meanwhile, operational subventions of up to eighty percent are also available. Consequently, these financial measures will significantly lower initial set-up barriers for manufacturers.
Reducing Import Dependence in Healthcare
Currently, India relies heavily on foreign imports for bulk drugs and advanced medical devices. However, this visionary framework directly addresses this critical supply gap. Furthermore, the policy actively promotes indigenous manufacturing and clinical research. As a result, domestic healthcare security will receive a massive boost. Therefore, physicians across India can expect improved access to high-quality local devices. Additionally, local production will likely reduce healthcare delivery costs, supporting those practicing in family medicine who serve the broader community.
Proposed Regulatory and Compliance Reforms
To support swift growth, AiMeD advocates for key compliance holidays. Specifically, Rajiv Nath urged governments to provide a three-year compliance holiday. Moreover, he recommended a one-year amnesty for existing units. Consequently, these steps will help units align with current regulations without facing operational disruptions. In addition, eliminating arbitrary requirements will ensure projects move forward confidently. Therefore, simpler approvals will accelerate medical innovation in the state, encouraging professionals to refine their expertise through comprehensive training programs.
Frequently Asked Questions
Q1: What are the main investment targets of the new policy?
The policy aims to attract over ten thousand crore rupees in investments and generate twenty thousand jobs.
Q2: How does the policy support green manufacturing?
Additionally, it provides attractive CAPEX and OPEX incentives that encourage sustainable and environmentally friendly practices.
References
- AiMeD hails Haryana’s ₹10,000 crore pharma, medtech manufacturing push – ETHealthworld
- Haryana Pharma Policy 2026: OPEX Support for Up to 10 Years – Vertex AI Search
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.